Scope
Description
The following medicines will be included in the tender:- Aflibercept, Golimumab, Dapagliflozin and Denosumab
Total value (estimated)
- £45,077,163 excluding VAT
- £54,092,595 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 January 2026 to 31 December 2027
- Possible extension to 31 December 2028
- 3 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKL - Wales
Engagement
Engagement deadline
16 October 2025
Engagement process description
This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).
There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Jen Tresilian (jennifer.tresilian@wales.nhs.uk).
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
17 October 2025
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- NHS Organisation Data Service: RQF
Imperial Park Unit 5, Celtic Way
Newport
NP10 8BE
United Kingdom
Contact name: Rachelle Elvin
Telephone: +442921500527
Email: rachelle.elvin@wales.nhs.uk
Website: http://nwssp.nhs.wales/ourservices/procurement-services/
Region: UKL21 - Monmouthshire and Newport
Organisation type: Public authority - central government
Devolved regulations that apply: Wales